Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Guieu, Régis"" wg kryterium: Autor


Wyświetlanie 1-12 z 12
Tytuł :
Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome.
Autorzy :
Frere C; a Service d'hématologie Biologique , Centre hospitalo-universitaire Timone , Marseille , France.; b Aix-Marseille Université, INSERM UMR-S 1076 , Vascular Research Center of Marseille , Marseille , France.
Laine M; c Service de cardiologie, Centre hospitalo-universitaire , Aix-Marseille université , Marseille , France.; d MARS cardio , Mediterraneen Association for research and studies in cardiology , Marseille , France.
Lemesle G; e Département de cardiologie , Centre hospitalo-universitaire de Lille , Lille , France.
Morange PE; a Service d'hématologie Biologique , Centre hospitalo-universitaire Timone , Marseille , France.; f Aix-Marseille Université , INSERM UMR1062, INRA UMR1260, Nutrition, Obesity and Risk of Thrombosis , Marseille , France.
Paganelli F; c Service de cardiologie, Centre hospitalo-universitaire , Aix-Marseille université , Marseille , France.
Dignat-George F; b Aix-Marseille Université, INSERM UMR-S 1076 , Vascular Research Center of Marseille , Marseille , France.
Resseguier N; g Aix-Marseille Université , Department of Biostatistics , Marseille , France.
Guieu R; h Research Unit of Physiology and Pathophysiology in Extreme Oxygenation Conditions (UMR MD2), Faculty of Medicine , Aix-Marseille University , Marseille , France.
Camoin-Jau L; a Service d'hématologie Biologique , Centre hospitalo-universitaire Timone , Marseille , France.
Bonello L; b Aix-Marseille Université, INSERM UMR-S 1076 , Vascular Research Center of Marseille , Marseille , France.; c Service de cardiologie, Centre hospitalo-universitaire , Aix-Marseille université , Marseille , France.; d MARS cardio , Mediterraneen Association for research and studies in cardiology , Marseille , France.
Pokaż więcej
Źródło :
Platelets [Platelets] 2019; Vol. 30 (1), pp. 105-111. Date of Electronic Publication: 2017 Nov 27.
Typ publikacji :
Journal Article
MeSH Terms :
Acute Coronary Syndrome/*complications
Fibrinolytic Agents/*therapeutic use
Heparin/*therapeutic use
Peptide Fragments/*therapeutic use
Percutaneous Coronary Intervention/*adverse effects
Thrombosis/*etiology
Thrombosis/*prevention & control
Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/metabolism ; Acute Coronary Syndrome/surgery ; Aged ; Blood Coagulation ; Blood Platelets/drug effects ; Blood Platelets/metabolism ; Female ; Hirudins ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention/methods ; Platelet Aggregation/drug effects ; Recombinant Proteins/therapeutic use ; Risk Factors
Czasopismo naukowe
Tytuł :
Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome.
Autorzy :
Gaubert M; Department of Cardiology, Hopital Nord, Marseille, France.
Marlinge M; Laboratory of Biochemistry, Hopital Timone, Marseille, France.; UMR MD2, Aix-Marseille University, Marseille, France.
Alessandrini M; EA 3279 Public Health, Chronic Disease and Quality of Life-Research Unit, Aix-Marseille University, Marseille, France.
Laine M; Department of Cardiology, Hopital Nord, Marseille, France.
Bonello L; Department of Cardiology, Hopital Nord, Marseille, France.
Fromonot J; Laboratory of Biochemistry, Hopital Timone, Marseille, France.; UMR MD2, Aix-Marseille University, Marseille, France.
Cautela J; Department of Cardiology, Hopital Nord, Marseille, France.
Thuny F; Department of Cardiology, Hopital Nord, Marseille, France.
Barraud J; Department of Cardiology, Hopital Nord, Marseille, France.
Mottola G; Laboratory of Biochemistry, Hopital Timone, Marseille, France.; UMR MD2, Aix-Marseille University, Marseille, France.
Rossi P; UMR MD2, Aix-Marseille University, Marseille, France.
Fenouillet E; UMR MD2, Aix-Marseille University, Marseille, France.; Institut des Sciences Biologiques, CNRS, Paris, France.
Ruf J; UMR MD2, Aix-Marseille University, Marseille, France.
Guieu R; Laboratory of Biochemistry, Hopital Timone, Marseille, France. guieu.regis@orange.fr.; UMR MD2, Aix-Marseille University, Marseille, France. guieu.regis@orange.fr.; Faculté de Médecine Nord, Boulevard P. Dramard, F-13015, Marseille, France. guieu.regis@orange.fr.
Paganelli F; Department of Cardiology, Hopital Nord, Marseille, France.
Pokaż więcej
Źródło :
Purinergic signalling [Purinergic Signal] 2018 Jun; Vol. 14 (2), pp. 191-199. Date of Electronic Publication: 2018 Apr 06.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Acute Coronary Syndrome/*blood
Biomarkers/*blood
Coronary Artery Disease/*blood
Endothelium, Vascular/*pathology
Uric Acid/*blood
Acute Coronary Syndrome/etiology ; Aged ; Coronary Angiography ; Coronary Artery Disease/complications ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Pleiotropic effects of ticagrelor: Myth or reality?
Autorzy :
Aït Mokhtar O; Department of Cardiology, CHU Mustapha Pacha, Alger, Algeria.
Gaubert M; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Laine M; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Bonello L; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Guieu R; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Cautela J; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Peyrol M; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Barraud J; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Thuny F; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Dignat-Georges F; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Sabatier F; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Fromonot J; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Rossi P; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France.
Paganelli F; Aix Marseille University and Department of Cardiology, North Hospital, chemin des Bourrely, 13008 Marseille, France. Electronic address: .
Pokaż więcej
Źródło :
Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2016 Aug-Sep; Vol. 109 (8-9), pp. 445-8. Date of Electronic Publication: 2016 Jun 21.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Acute Coronary Syndrome/*drug therapy
Adenosine/*analogs & derivatives
Adenosine/pharmacology ; Humans ; Purinergic P2Y Receptor Antagonists/pharmacology ; Ticagrelor ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.
Autorzy :
Bonello L; Laurent Bonello MD, PhD, Département de Cardiologie, Hôpital universitaire Nord de Marseille, INSERM UMRS 1076, Aix-Marseille Université, Chemin des Bourrely, Marseille 13015, France, Tel.: +33 491968858, Fax: +33 491968979, E-mail: .
Laine M
Camoin-Jau L
Noirot F
Guieu R
Dignat-George F
Paganelli F
Frere C
Pokaż więcej
Źródło :
Thrombosis and haemostasis [Thromb Haemost] 2015 Oct; Vol. 114 (4), pp. 702-7. Date of Electronic Publication: 2015 Aug 27.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Percutaneous Coronary Intervention*
Acute Coronary Syndrome/*therapy
Adenosine/*analogs & derivatives
Blood Platelets/*drug effects
Platelet Aggregation/*drug effects
Platelet Aggregation Inhibitors/*administration & dosage
Prasugrel Hydrochloride/*administration & dosage
Purinergic P2Y Receptor Antagonists/*administration & dosage
Receptors, Purinergic P2Y12/*drug effects
Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/diagnosis ; Acute Coronary Syndrome/drug therapy ; Adenosine/administration & dosage ; Biomarkers/blood ; Blood Platelets/metabolism ; Cell Adhesion Molecules/blood ; France ; Humans ; Microfilament Proteins/blood ; Phosphoproteins/blood ; Platelet Function Tests ; Prospective Studies ; Receptors, Purinergic P2Y12/blood ; Ticagrelor ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes.
Autorzy :
Bonello L; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, Marseille, France; Vascular Research Center of Marseille, INSERM UMR-S 1076, Aix-Marseille Université, Marseille, France. Electronic address: .
Laine M; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, Marseille, France.
Cluzel M; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, Marseille, France.
Frere C; Vascular Research Center of Marseille, INSERM UMR-S 1076, Aix-Marseille Université, Marseille, France.
Mancini J; BiosTIC, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France; Faculté de Médecine de Marseille, INSERM, IRD, UMR_S912, SESSTIM, Aix-Marseille Université, Marseille, France.
Hasan A; Service de Cardiologie, Hôpital de Martigues, Martigues, France.
Thuny F; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, Marseille, France.
Gaubert M; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, Marseille, France.
Guieu R; UMR MD2, Aix-Marseille Université, Marseille, France; Laboratory of Biochemistry, Timone University Hospital, Marseille, France.
Dignat-George F; Vascular Research Center of Marseille, INSERM UMR-S 1076, Aix-Marseille Université, Marseille, France; Laboratoire d'Hématologie et de Biologie Vasculaire, Centre Hospitalo-Universitaire de la Conception, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
Michelet P; UMR MD2, Aix-Marseille Université, Marseille, France; Service d'accueil des urgences Hôpital Timone, Marseille, France.
Paganelli F; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, Marseille, France.
Kerbaul F; UMR MD2, Aix-Marseille Université, Marseille, France; Pole RUSH, Assistance Publique-Hôpitaux de Marseille, Marseille, France.
Pokaż więcej
Źródło :
The American journal of cardiology [Am J Cardiol] 2015 Aug 01; Vol. 116 (3), pp. 339-43. Date of Electronic Publication: 2015 May 09.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Electrocardiography*
Acute Coronary Syndrome/*drug therapy
Adenosine/*analogs & derivatives
Myocardial Infarction/*prevention & control
Piperazines/*administration & dosage
Thiophenes/*administration & dosage
Acute Coronary Syndrome/complications ; Acute Coronary Syndrome/diagnosis ; Adenosine/administration & dosage ; Adolescent ; Adult ; Aged ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myocardial Infarction/etiology ; Prasugrel Hydrochloride ; Prospective Studies ; Purinergic P2Y Receptor Antagonists/administration & dosage ; Ticagrelor ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study.
Autorzy :
Bonello L; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, France; Vascular Research Center of Marseille, INSERM UMR-S 1076, Aix-Marseille Université, Marseille, France. Electronic address: .
Frere C; Vascular Research Center of Marseille, INSERM UMR-S 1076, Aix-Marseille Université, Marseille, France.
Cointe S; Vascular Research Center of Marseille, INSERM UMR-S 1076, Aix-Marseille Université, Marseille, France.
Laine M; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, France.
Mancini J; Assistance Publique-Hôpitaux de Marseille, Hôpital de la Timone, BiosTIC, France; Aix-Marseille Université, Inserm, IRD, UMR_S912, SESSTIM, Faculté de Médecine de Marseille, France.
Thuny F; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, France.
Kerbaul F; Research Unit of Physiology and Pathophysiology in Extreme Oxygenation Conditions (UMR MD2), Faculty of Medicine, Aix-Marseille University, Marseille, France; Pole RUSH, Assistance-Publique Hôpitaux de Marseille, Marseille, France.
Lemesle G; Service de Cardiologie, CHRU de Lille, Lille, France.
Paganelli F; Service de Cardiologie, Centre Hospitalier Universitaire de Marseille, Hôpital NORD, Aix-Marseille Université, France.
Guieu R; Research Unit of Physiology and Pathophysiology in Extreme Oxygenation Conditions (UMR MD2), Faculty of Medicine, Aix-Marseille University, Marseille, France.
Arnaud L; Vascular Research Center of Marseille, INSERM UMR-S 1076, Aix-Marseille Université, Marseille, France; Laboratoire d'Hématologie et de Biologie Vasculaire, Assistance-Publique Hôpitaux de Marseille, Centre hospitalo-universitaire de la Conception, Marseille, France.
Dignat-George F; Vascular Research Center of Marseille, INSERM UMR-S 1076, Aix-Marseille Université, Marseille, France; Laboratoire d'Hématologie et de Biologie Vasculaire, Assistance-Publique Hôpitaux de Marseille, Centre hospitalo-universitaire de la Conception, Marseille, France.
Sabatier F; Vascular Research Center of Marseille, INSERM UMR-S 1076, Aix-Marseille Université, Marseille, France; Laboratoire d'Hématologie et de Biologie Vasculaire, Assistance-Publique Hôpitaux de Marseille, Centre hospitalo-universitaire de la Conception, Marseille, France.
Pokaż więcej
Źródło :
International journal of cardiology [Int J Cardiol] 2015; Vol. 187, pp. 502-7. Date of Electronic Publication: 2015 Mar 31.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Acute Coronary Syndrome/*drug therapy
Acute Coronary Syndrome/*surgery
Adenosine/*analogs & derivatives
Endothelial Progenitor Cells/*drug effects
Purinergic P2Y Receptor Antagonists/*administration & dosage
Ticlopidine/*analogs & derivatives
Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/pathology ; Adenosine/administration & dosage ; Adenosine/adverse effects ; Aged ; Antigens, CD34/biosynthesis ; Body Mass Index ; Clopidogrel ; Endothelial Progenitor Cells/metabolism ; Endothelial Progenitor Cells/pathology ; Female ; Humans ; Male ; Middle Aged ; Percutaneous Coronary Intervention/methods ; Prospective Studies ; Purinergic P2Y Receptor Antagonists/adverse effects ; Ticagrelor ; Ticlopidine/administration & dosage ; Ticlopidine/adverse effects
Czasopismo naukowe
Tytuł :
Reply: Adenosine plasma concentration increase by ticagrelor in patients with acute coronary syndrome: no cause for fear in clinical practice.
Autorzy :
Bonello L
Kipson N
Mancini J
Frere C
Paganelli F
Dignat-George F
Guieu R
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2014 Jun 10; Vol. 63 (22), pp. 2436-7. Date of Electronic Publication: 2014 Mar 13.
Typ publikacji :
Letter; Comment
MeSH Terms :
Acute Coronary Syndrome/*blood
Acute Coronary Syndrome/*drug therapy
Adenosine/*analogs & derivatives
Adenosine/*blood
Purinergic P2Y Receptor Antagonists/*therapeutic use
Female ; Humans ; Male
Opinia redakcyjna
Tytuł :
Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.
Autorzy :
Bonello L; Département de Cardiologie, Hôpital Universitaire Nord de Marseille, Assistance-Publique Hôpitaux de Marseille, Marseille, France; INSERM UMRS 1076, Aix-Marseille University, Marseille, France. Electronic address: .
Laine M; Département de Cardiologie, Hôpital Universitaire Nord de Marseille, Assistance-Publique Hôpitaux de Marseille, Marseille, France.
Kipson N; Research Unit of Physiology and Dysoxia and suractivity, UMR MD2 and Institute of Biological Research, French Defense Ministry (IRBA), Marseille, France.
Mancini J; Assistance Publique, Hôpitaux de Marseille, Hôpital de la Timone, SSPIM, France; Aix-Marseille Université, Faculté de Médecine de Marseille, LERTIM (EA 3283), Marseille, France.
Helal O; Département de Cardiologie, Hôpital Universitaire Nord de Marseille, Assistance-Publique Hôpitaux de Marseille, Marseille, France.
Fromonot J; Research Unit of Physiology and Dysoxia and suractivity, UMR MD2 and Institute of Biological Research, French Defense Ministry (IRBA), Marseille, France.
Gariboldi V; Research Unit of Physiology and Dysoxia and suractivity, UMR MD2 and Institute of Biological Research, French Defense Ministry (IRBA), Marseille, France.
Condo J; Research Unit of Physiology and Dysoxia and suractivity, UMR MD2 and Institute of Biological Research, French Defense Ministry (IRBA), Marseille, France.
Thuny F; Département de Cardiologie, Hôpital Universitaire Nord de Marseille, Assistance-Publique Hôpitaux de Marseille, Marseille, France.
Frere C; INSERM UMRS 1076, Aix-Marseille University, Marseille, France.
Camoin-Jau L; INSERM UMRS 1076, Aix-Marseille University, Marseille, France.
Paganelli F; Département de Cardiologie, Hôpital Universitaire Nord de Marseille, Assistance-Publique Hôpitaux de Marseille, Marseille, France.
Dignat-George F; INSERM UMRS 1076, Aix-Marseille University, Marseille, France; Laboratoire d'Hématologie et de Biologie Vasculaire, Assistance-Publique Hôpitaux de Marseille, Centre Universitaire de la Conception, Marseille, France.
Guieu R; Research Unit of Physiology and Dysoxia and suractivity, UMR MD2 and Institute of Biological Research, French Defense Ministry (IRBA), Marseille, France; Laboratoire de Biochimie, Hôpital Universitaire Nord de Marseille, Assistance-Publique Hôpitaux de Marseille, Marseille, France.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2014 Mar 11; Vol. 63 (9), pp. 872-7. Date of Electronic Publication: 2013 Nov 27.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Acute Coronary Syndrome/*blood
Acute Coronary Syndrome/*drug therapy
Adenosine/*analogs & derivatives
Adenosine/*blood
Purinergic P2Y Receptor Antagonists/*therapeutic use
Adenosine/therapeutic use ; Adenosine Deaminase/metabolism ; Aged ; C-Reactive Protein/metabolism ; Chromatography, Liquid ; Clopidogrel ; Cyclic AMP/blood ; Erythrocytes/drug effects ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Ticagrelor ; Ticlopidine/analogs & derivatives ; Ticlopidine/therapeutic use
Czasopismo naukowe
Tytuł :
Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes.
Autorzy :
Bali L; Department of Cardiology, CHU La-Timone, 264, rue Saint-Pierre, 13005 Marseille, France. />Cuisset T
Giorgi R
Monserrat C
Quilici J
Carrega L
Mouret JP
Nait-Saidi L
Mielot C
Lambert M
Guieu R
Bonnet JL
Pokaż więcej
Źródło :
Archives of cardiovascular diseases [Arch Cardiovasc Dis] 2008 Oct; Vol. 101 (10), pp. 645-51. Date of Electronic Publication: 2008 Nov 06.
Typ publikacji :
Journal Article
MeSH Terms :
Acute Coronary Syndrome/*blood
Biomarkers/*blood
Serum Albumin/*analysis
Aged ; Aged, 80 and over ; C-Reactive Protein/analysis ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; ROC Curve
Czasopismo naukowe
    Wyświetlanie 1-12 z 12

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies